SCHEMBL74380

SCHEMBL74380

COc1ccccc1S(=O)(=O)Cl

nearest known ligand 0.60

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ HTR6 P50406 1/20 0.60
▸ TRPV4 Q9HBA0 1/20 0.58
▸ NFE2L2 Q16236 9/20 0.50
▸ KCNH2 Q12809 1/20 0.50
▸ CA12 O43570 1/20 0.50
▸ CA1 P00915 1/20 0.50
▸ CA2 P00918 1/20 0.50
▸ CA4 P22748 1/20 0.50
▸ CA7 P43166 1/20 0.50
▸ CA9 Q16790 1/20 0.50
▸ CA14 Q9ULX7 1/20 0.50
▸ NPC1 O15118 1/20 0.45
▸ TSHR P16473 1/20 0.45
▸ KMT2A Q03164 1/20 0.44
▸ PKM P14618 1/20 0.44
▸ SLC22A12 Q96S37 1/20 0.42
▸ KAT6A Q92794 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29490409 1.00 HTR6 (0.60) HTR6TRPV4NFE2L2KCNH2CA12
SCHEMBL7205989 0.82 TRPV4 (0.42) HTR6TRPV4NFE2L2KCNH2CA12
SCHEMBL31352974 0.82 HTR6 (0.77) HTR6NFE2L2KCNH2CA12CA1
SCHEMBL31387938 0.82 TRPV4 (0.42) HTR6TRPV4NFE2L2KCNH2CA12
SCHEMBL22980481 0.82 TRPV4 (0.53) HTR6TRPV4NFE2L2KCNH2CA12
SCHEMBL1713241 0.82 TRPV4 (0.49) HTR6TRPV4NFE2L2KCNH2CA12
SCHEMBL5984084 0.82 TRPV4 (0.49) HTR6TRPV4NFE2L2KCNH2CA12
SCHEMBL29969255 0.82 TRPV4 (0.49) HTR6TRPV4NFE2L2KCNH2CA12
1,2-Dimethoxybenzene SCHEMBL66189 0.81 CA1 (0.68) HTR6TRPV4NFE2L2CA12CA1
SCHEMBL29651874 0.80 TRPV4 (0.47) HTR6TRPV4NFE2L2KCNH2CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 990 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119425423-A Positively charged composite membrane and preparation method and application thereof 中国石油化工股份有限公司 2025-02-14 — — CN claimed
CN-114524811-B LXH0307 and LXH0308 as small molecule inhibitors for gene editing and application thereof 中国人民解放军军事科学院军事医学研究院 2025-01-24 — — CN claimed
CN-118496175-A TRADD inhibitor derivative and preparation method and application thereof 安徽医科大学 2024-08-16 — — CN claimed
CN-114524811-A LXH0307 and LXH0308 as small molecule inhibitors of gene editing and application thereof 中国人民解放军军事科学院军事医学研究院 2022-05-24 — — CN claimed
CN-111100044-B Preparation method of alkyl zinc sulfinate series compounds 鹤壁元昊化工有限公司 2020-10-16 — — CN claimed
CN-110467551-A A kind of 4- methoxyl group-N- (1- naphthalene) benzene sulfonamide STAT3 micromolecular inhibitor and its preparation and application UNIV WENZHOU MEDICAL 2019-11-19 — — CN claimed
CN-110156942-A A kind of preparation method and application of comb block polycarboxylic acid super-plasticizer 中科广化(重庆)新材料研究院有限公司 2019-08-23 — — CN claimed
CN-109694338-A A kind of methoxyacetophenone derivative and preparation method thereof, application 河南科技大学 2019-04-30 — — CN claimed
CN-109678784-A Thioetherification Benzazole compounds and preparation method thereof 天津师范大学 2019-04-26 — — CN claimed
CN-107176915-B A kind of synthetic method of alkene sulfone compound 同济大学 2019-01-25 — — CN claimed
CN-104497183-A Method for preparing phthalate imprinted polymer by atom transfer radical polymerization method UNIV HENAN TECHNOLOGY 2015-04-08 — — CN claimed
CN-104262306-A Method for preparing citalopram and S-citalopram ZHEJIANG HUAHAI PHARM CO LTD 2015-01-07 — — CN claimed
CN-104230836-A Phenyloxazole compounds and application thereof to preparation of medicament for treating cancers CHENGDU INST BIOLOGY CAS 2014-12-24 — — CN claimed
CN-101848891-A Preparation of synthetic nucleosides by pi-allyl transition metal complex formation UNIV EMORY 2010-09-29 — — CN claimed
US-20100204463-A1 Preparation Of Synthetic Nucleosides via Pi-Allyl Transition Metal Complex Formation EMORY UNIVERSITY 2010-08-12 — — US claimed
EP-2185508-A1 PREPARATION OF SYNTHETIC NUCLEOSIDES VIA pi-ALLYL TRANSITION METAL COMPLEX FORMATION Emory University (US) 2010-05-19 — — EP claimed
WO-2009021114-A1 PREPARATION OF SYNTHETIC NUCLEOSIDES VIA π-ALLYL TRANSITION METAL COMPLEX FORMATION EMORY UNIVERSITY (US) 2009-02-12 — — WO claimed
US-6455738-B1 FRIEDEL-CRAFT CATALYSIS IN THE PRESENCE OF MIXTURES OF LEWIS ACIDS AND SULFONIC ACID ESTERS AS FRIEDEL CRAFT'S CATALYSTS; STOICHIOMETRY RHODIA CHIMIE (FR) 2002-09-24 — — US claimed
US-6348631-B1 REACTING AROMATIC COMPOUND WITH ACYLATING OR SULFONYLATING AGENT IN PRESENCE OF FRIEDEL-CRAFTS CATALYST, WHEREIN ACYLATION OR SULFONYLATION REACTION IS CARRIED OUT IN LIQUID PHASE UNDER MICROWAVE IRRADIATION RHODIA CHIMIE (FR) 2002-02-19 — — US claimed
WO-2001068726-A1 ATOM TRANSFER RADICAL POLYMERISATION CATALYST BP CHEMICALS LIMITED (GB) 2001-09-20 — — WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100204463-A1 Preparation Of Synthetic Nucleosides via Pi-Allyl Transition Metal Complex Formation PAICS, POLRMT, ZC3HAV1 HTR6 4491/4885TRPV4 2840/4885NFE2L2 4464/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback